Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Fort Wayne Medical Oncology and Hematology Inc-Parkview
717
mi
from
Fort Wayne, IN
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Fort Wayne Medical Oncology and Hematology Inc-Parkview
717
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
University of Iowa - Holden Comprehensive Cancer Center
429
mi
from
Iowa City, IA
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
University of Iowa - Holden Comprehensive Cancer Center
429
mi
from
Iowa City, IA
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Spectrum Health Big Rapids Hospital
764
mi
from
Big Rapids, MI
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Spectrum Health Big Rapids Hospital
764
mi
from
Big Rapids, MI
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Research Consortium of West Michigan NCORP
733
mi
from
Grand Rapids, MI
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Research Consortium of West Michigan NCORP
733
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Mercy Health Saint Mary's
733
mi
from
Grand Rapids, MI
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Mercy Health Saint Mary's
733
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Mercy Health Mercy Campus
715
mi
from
Muskegon, MI
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Mercy Health Mercy Campus
715
mi
from
Muskegon, MI
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cooper Hospital University Medical Center
1227
mi
from
Camden, NJ
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cooper Hospital University Medical Center
1227
mi
from
Camden, NJ
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
UNC Lineberger Comprehensive Cancer Center
1038
mi
from
Chapel Hill, NC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
UNC Lineberger Comprehensive Cancer Center
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Novant Health Presbyterian Medical Center
958
mi
from
Charlotte, NC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Novant Health Presbyterian Medical Center
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Margaret R Pardee Memorial Hospital
868
mi
from
Hendersonville, NC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Margaret R Pardee Memorial Hospital
868
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
810
mi
from
Columbus, OH
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital Oklahoma City
148
mi
from
Oklahoma City, OK
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Oklahoma City
148
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Greenville Health System Cancer Institute-Butternut
883
mi
from
Greenville, SC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute-Butternut
883
mi
from
Greenville, SC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Greenville Health System Cancer Institute-Faris
883
mi
from
Greenville, SC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute-Faris
883
mi
from
Greenville, SC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Greenville Health System Cancer Institute/Eastside
883
mi
from
Greenville, SC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute/Eastside
883
mi
from
Greenville, SC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Greenville Health System Cancer Institute-Seneca
854
mi
from
Seneca, SC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute-Seneca
854
mi
from
Seneca, SC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Greenville Health System Cancer Institute-Spartanburg
903
mi
from
Spartanburg, SC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute-Spartanburg
903
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
University of Vermont College of Medicine
1356
mi
from
Burlington, VT
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
University of Vermont College of Medicine
1356
mi
from
Burlington, VT
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Union Hospital of Cecil County
1189
mi
from
Elkton, MD
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Union Hospital of Cecil County
1189
mi
from
Elkton, MD
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Northwell Health NCORP
1303
mi
from
Lake Success, NY
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Northwell Health NCORP
1303
mi
from
Lake Success, NY
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
1336
mi
from
New York, NY
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
1336
mi
from
New York, NY
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Greenville Health System Cancer Institute-Greer
886
mi
from
Greer, SC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute-Greer
886
mi
from
Greer, SC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
MedStar Georgetown University Hospital
1127
mi
from
Washington,
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
MedStar Georgetown University Hospital
1127
mi
from
Washington,
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Central Vermont Medical Center/National Life Cancer Treatment
1383
mi
from
Berlin, VT
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Central Vermont Medical Center/National Life Cancer Treatment
1383
mi
from
Berlin, VT
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Northwell Health- Center for Advanced Medicine
1302
mi
from
Lake Success, NY
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Northwell Health- Center for Advanced Medicine
1302
mi
from
Lake Success, NY
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Vidant Oncology-Kinston
1138
mi
from
Kinston, NC
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Vidant Oncology-Kinston
1138
mi
from
Kinston, NC
Click here to add this to my saved trials
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
NYP Weill Cornell Medical Center
1289
mi
from
New York, NY
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
NYP Weill Cornell Medical Center
1289
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS007)
Status: Enrolling
Updated:  12/31/1969
University of Virginia Center for Research in Reproduction
1053
mi
from
Charlottesville, VA
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS007)
Status: Enrolling
Updated: 12/31/1969
University of Virginia Center for Research in Reproduction
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS003)
Status: Enrolling
Updated:  12/31/1969
University of Virginia Center for Research in Reproduction
1053
mi
from
Charlottesville, VA
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS003)
Status: Enrolling
Updated: 12/31/1969
University of Virginia Center for Research in Reproduction
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction in Overweight Early Pubertal Girls With Androgen Excess (CBS0004)
Status: Enrolling
Updated:  12/31/1969
University of Virginia Center for Research in Reproduction
1053
mi
from
Charlottesville, VA
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction in Overweight Early Pubertal Girls With Androgen Excess (CBS0004)
Status: Enrolling
Updated: 12/31/1969
University of Virginia Center for Research in Reproduction
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenemic Adolescent Girls (JCM025)
Status: Enrolling
Updated:  12/31/1969
Center for Research in Reproduction, University of Virginia
1053
mi
from
Charlottesville, VA
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenemic Adolescent Girls (JCM025)
Status: Enrolling
Updated: 12/31/1969
Center for Research in Reproduction, University of Virginia
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
Effect of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenic Adolescent Girls (JCM021)
Status: Enrolling
Updated:  12/31/1969
Center for Research in Reproduction, University of Virginia
1053
mi
from
Charlottesville, VA
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
Effect of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenic Adolescent Girls (JCM021)
Status: Enrolling
Updated: 12/31/1969
Center for Research in Reproduction, University of Virginia
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Early Pubertal Girls (JCM026)
Status: Enrolling
Updated:  12/31/1969
Center for Research in Reproduction, University of Virginia
1053
mi
from
Charlottesville, VA
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Early Pubertal Girls (JCM026)
Status: Enrolling
Updated: 12/31/1969
Center for Research in Reproduction, University of Virginia
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Family Nurture Intervention (FNI) in Neonatal Intensive Care Unit (NICU)
Enhancement of Co-regulation Between Mother and Infant Via Family Nurture Intervention (FNI) in the NICU: Short and Long Term Effects on Development
Status: Enrolling
Updated:  12/31/1969
Morgan Stanley Children's Hospital
1290
mi
from
New York, NY
Family Nurture Intervention (FNI) in Neonatal Intensive Care Unit (NICU)
Enhancement of Co-regulation Between Mother and Infant Via Family Nurture Intervention (FNI) in the NICU: Short and Long Term Effects on Development
Status: Enrolling
Updated: 12/31/1969
Morgan Stanley Children's Hospital
1290
mi
from
New York, NY
Click here to add this to my saved trials
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
Effect of Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding Continuation, Contraceptive Continuation, and Postpartum Depression: a Randomized Trial
Status: Enrolling
Updated:  12/31/1969
Center for Family Planning Research, Magee-Womens Hospital
971
mi
from
Pittsburgh, PA
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
Effect of Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding Continuation, Contraceptive Continuation, and Postpartum Depression: a Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Center for Family Planning Research, Magee-Womens Hospital
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Aptos Women's Health Center
1319
mi
from
Aptos, CA
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Aptos Women's Health Center
1319
mi
from
Aptos, CA
Click here to add this to my saved trials
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Dominican Hospital
1323
mi
from
Santa Cruz, CA
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Dominican Hospital
1323
mi
from
Santa Cruz, CA
Click here to add this to my saved trials
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine, Lucile Packard Children's Hospital
1329
mi
from
Stanford, CA
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine, Lucile Packard Children's Hospital
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers
Preventing Postpartum Depression in Adolescent Mothers
Status: Enrolling
Updated:  12/31/1969
Women and Infants Hospital
1424
mi
from
Providence, RI
Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers
Preventing Postpartum Depression in Adolescent Mothers
Status: Enrolling
Updated: 12/31/1969
Women and Infants Hospital
1424
mi
from
Providence, RI
Click here to add this to my saved trials
Silo Versus Primary Closure for Gastroschisis
Bedside Silo Versus Attempted Operative Closure for Gastroschisis
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
198
mi
from
Kansas City, MO
Silo Versus Primary Closure for Gastroschisis
Bedside Silo Versus Attempted Operative Closure for Gastroschisis
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
198
mi
from
Kansas City, MO
Click here to add this to my saved trials
Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery
Comparison of Staples Versus Nonabsorbable Subcuticular (Prolene) Suture for Skin Closure in Cesarean Deliveries: A Randomized Study
Status: Enrolling
Updated:  12/31/1969
Lucile Packard Children's Hospital
1329
mi
from
Palo Alto, CA
Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery
Comparison of Staples Versus Nonabsorbable Subcuticular (Prolene) Suture for Skin Closure in Cesarean Deliveries: A Randomized Study
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A MRI Study of Visual and Motor Pathways in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital
372
mi
from
Little Rock, AR
A MRI Study of Visual and Motor Pathways in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
Brain-Derived Neurotrophic Factor in Obesity and Brain Function
Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Brain-Derived Neurotrophic Factor in Obesity and Brain Function
Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Brain-Derived Neurotrophic Factor in Obesity and Brain Function
Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function
Status: Enrolling
Updated:  12/31/1969
University of Alberta
1321
mi
from
Alberta,
Brain-Derived Neurotrophic Factor in Obesity and Brain Function
Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function
Status: Enrolling
Updated: 12/31/1969
University of Alberta
1321
mi
from
Alberta,
Click here to add this to my saved trials
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
1444
mi
from
Boston, MA
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Minimizing Physical Function Decline in Older Adults Receiving Chemotherapy
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
979
mi
from
Winston-Salem, NC
Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Minimizing Physical Function Decline in Older Adults Receiving Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
979
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Cervical Cancer Screening Among Hispanic Women
Cervical Cancer Screening and Adherence to Follow-up Among Hispanic Women
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
1410
mi
from
Seattle, WA
Cervical Cancer Screening Among Hispanic Women
Cervical Cancer Screening and Adherence to Follow-up Among Hispanic Women
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
A Phase II Trial of Reduced Intensity Allogeneic Stem Cell Transplantation With Fludarabine, Melphalan and Low Dose Total Body Irradiation
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
A Phase II Trial of Reduced Intensity Allogeneic Stem Cell Transplantation With Fludarabine, Melphalan and Low Dose Total Body Irradiation
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Click here to add this to my saved trials